Myomo (MYO) Research & Development (2016 - 2025)
Myomo posted quarterly Research & Development of $1.5 million for Q3 2025, up 22.32% year-on-year from $1.2 million in Q3 2024, and down 23.67% on a QoQ basis from $2.0 million in Q2 2025.
Myomo (MYO) has 10 years of Research & Development data on file, last reported at $1.5 million in Q3 2025.
- For the quarter ending Q3 2025, Research & Development rose 22.32% year-over-year to $1.5 million; the trailing twelve-month figure through Sep 2025 stood at $6.9 million (up 68.17% YoY), and the FY2024 full-year result was $4.8 million, up 81.0% from the prior year.
- Research & Development for Q3 2025 stood at $1.5 million, down from $2.0 million in the prior quarter.
- Across five years, Research & Development topped out at $2.0 million in Q2 2025 and bottomed at $476991.0 in Q1 2023.
- The 5-year median for Research & Development is $717256.0 (2023), against an average of $934997.1.
- The widest annual swing landed in 2022, when Research & Development plunged 36.56%; it then soared 100.47% in 2024.
- A 5-year view of Research & Development shows it stood at $787628.0 in 2021, then tumbled by 36.56% to $499674.0 in 2022, then jumped by 75.72% to $878007.0 in 2023, then jumped by 77.64% to $1.6 million in 2024, then retreated by 2.05% to $1.5 million in 2025.
- The last three Research & Development figures came in at $1.5 million (Q3 2025), $2.0 million (Q2 2025), and $1.8 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 956,215.00 |
| Dec 31, 2023 | 878,007.00 |
| Sep 30, 2023 | 717,256.00 |
| Jun 30, 2023 | 564,235.00 |
| Mar 31, 2023 | 476,991.00 |
| Dec 31, 2022 | 499,674.00 |
| Sep 30, 2022 | 690,407.00 |
| Jun 30, 2022 | 632,872.00 |
| Mar 31, 2022 | 659,536.00 |
| Dec 31, 2021 | 787,628.00 |
| Sep 30, 2021 | 641,228.00 |
| Jun 30, 2021 | 600,116.00 |
| Mar 31, 2021 | 525,967.00 |
| Dec 31, 2020 | 418,758.00 |
| Sep 30, 2020 | 345,666.00 |
| Jun 30, 2020 | 397,811.00 |
| Mar 31, 2020 | 506,953.00 |
| Dec 31, 2019 | 442,523.00 |
| Sep 30, 2019 | 433,065.00 |
| Jun 30, 2019 | 427,573.00 |
| Mar 31, 2019 | 446,348.00 |
| Dec 31, 2018 | 529,619.00 |
| Sep 30, 2018 | 449,673.00 |
| Jun 30, 2018 | 486,982.00 |
| Mar 31, 2018 | 372,359.00 |
| Dec 31, 2017 | 356,866.00 |
| Sep 30, 2017 | 329,357.00 |
| Jun 30, 2017 | 708,622.00 |
| Mar 31, 2017 | 356,885.00 |
| Dec 31, 2016 | 406,618.00 |
| Sep 30, 2016 | 237,688.00 |
| Jun 30, 2016 | 258,282.00 |